Guidelines for TrimesTer-specific Thyroid-sTimulaTinG hormone
Current guidelines on the management of thyroid disorders during pregnancy strongly recommend the establishment of population-based trimester-specific reference ranges for thyroid-stimulating hormone (TSH). [1] This is an important aspect of clinical endocrinology, as the reference range directly impacts clinical decision-making and institution of therapy. Population-based reference ranges are expected to be calculated based on data of healthy pregnant women, with no personal or family history of thyroid dysfunction, no visible or palpable goiter; history of thyroid disease, with optimal iodine intake; and negative thyroid peroxidase antibody status. In accordance with the International Federation of Clinical Chemistry, [2] reference intervals should extend from the 2.5 th to 97.5 th percentile. [3, 4] While standard investigations require a minimum of 120 measurements for the establishment of normal ranges, thyroid function tests need a minimum of 400 individual measurements for validation of healthy reference ranges. [5] This is due to the high interindividual variability and skewness of data.
VariabiliTy of Thyroid-sTimulaTinG hormone
Factors to be considered in the interpretation of TSH in pregnancy are preanalytical factors such as gestational age, presence of thyroid antibodies, iodine status, multiple pregnancies, ethnicity, and time of collection of TSH sample. Serum human chorionic gonadotropin concentrations tend to be higher, and TSH concentrations tend to be lower in women with multiple pregnancies. [6] Circadian TSH rhythm has been observed in pregnant women as well as in nonpregnant women, with this circadian variation persisting in the second and third trimesters. Thus, failure to standardize collection time may interfere with the results and interpretation of the tests. [7] Different immunoassays result in different TSH values. In general, the 97.5 th percentile of TSH for the first trimester is located in two groups: according to the Architect, Beckman, and Immulite platform, it is about 3.0 mIU/L, while according to Centaur and Roche, it is close to 4 mIU/L. [6] indian daTa Over the past few years, Indian endocrinologists have worked hard to identify center-based or population-based trimester-specific data for TSH. Perhaps the first effort in this direction, by Kumar et al., from New Delhi, is available online only in abstract form. [8] The seminal effort of 2008 by Marwaha et al., from New Delhi, continues to enjoy sempiternal relevance. [9] This work has been expanded upon by Sekhri et al. from the same institute [10] and complemented by authors from Haryana, Maharashtra, and Manipur. [11] [12] [13] A well-conducted study from Bengal has also been published in 2014. [14] However, as this uses ELISA techniques to measure thyroid function tests, its relevance to modern thyroidology is debatable.
heTeroGeneiTy in desiGn and resulTs
In this editorial, we compare the data from the six relevant published studies on trimester-specific ranges for thyroid function tests [Tables 1-3 ]. Broadly speaking, these studies have similar inclusion and exclusion criteria. Some are longitudinal in nature, whereas others are cross-sectional. Some studies rely on dietary history to assess iodine sufficiency, whereas others measure urinary iodide concentration to prove the same. Ultrasonography and thyroid antibodies screening are done by some, but not all authors for exclusion of nonhealthy participants. Most, authors mention the details of their kits, including sensitivity, coefficients of variation, nonpregnant reference ranges, and manufacturer identity. Some choose to report 5 th and 95 th percentile cutoffs, others prefer 2.5 th and 97.5 th percentiles, and yet others mention both. All mention mean values of thyroid function tests, whereas only four report median values. All but two measure free T3 and free T4 [ Table 4 ]. This heterogeneity makes it difficult to compare these data sets. An eyeball analysis of the Indian data suggests that there is high heterogeneity between the various data sets. The lowest reference ranges are reported from Manipur and the highest from New Delhi. Rohtak and Nagpur reference ranges fall between those reported from Manipur and the national capital.
need for harmony
Reference ranges are of two types: health associated and decision based. The data discussed above are health associated, as it communicates thyroid function status of healthy Indian women. This does not necessarily translate into decision-making utility. [15] To do so, we need more robust data from all parts of the country, which can be analyzed together. We appreciate the opinion of Jebasingh et al., who highlight the multifaceted ethnic makeup of our country. [13] However, in a situation where limited funds are available, it makes sense to harmonize not only assays but also research methodology. [16, 17] This will help create a pan-India reference range for thyroid function tests not only in pregnancy [18] but also in other age groups. [15, 19, 20] These can be used to inform accurate and appropriate clinical decision-making throughout the country. Kumar et al. (2003) [6] New Delhi Kumar et al. (2003) [6] New 
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